Niels Martin, MD
Trauma Surgery · Philadelphia, PANPI 1013073477
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $194,230 of the $252,971 with a category attached, or 76.8%. AstraZeneca accounts for 75.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $59,914 and has fallen 98.9% since, to $631 in 2025. Among trauma surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 288 payments — averaging $878.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$191K
- Portola Pharmaceuticals, LLC$47K
- Astrazeneca UK Limited$12K
- BTG International Inc.$2K
- BD$350
- Bard Access Systems, Inc.$300
- plus $1K from 8 others
Across 35 payments — averaging $1805.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$42K
- AstraZeneca$21K
What the payments were for
- Consulting fees$32,69513%
- Speaking & faculty fees$194,23077%
- Travel & lodging$18,0807%
- Food & beverage$7,9663%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 192 | $190,881 |
| Portola Pharmaceuticals, LLC | 69 | $46,889 |
| Astrazeneca UK Limited | 4 | $11,680 |
| BTG International Inc. | 3 | $1,573 |
| BD | 1 | $350 |
| Bard Access Systems, Inc. | 1 | $300 |
| Bard Peripheral Vascular, Inc. | 1 | $300 |
| Prytime Medical Devices, Inc. | 7 | $284 |
| KCI USA, Inc. | 1 | $197 |
| Edwards Lifesciences | 4 | $183 |
| Baxter Healthcare | 2 | $144 |
| Octapharma USA, Inc. | 1 | $108 |
| Teleflex LLC | 1 | $66 |
| Zimmer Biomet | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$231,625
- HemoSphere$350
- ABTHERA$197
- ER-REBOA PLUS$119
- FLOSEAL$118
- FIBRYGA$108
How this compares
$252,971 in reported general payments places this provider in the 95th percentile of 84 trauma surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other trauma surgery in Philadelphia
- Adam ShiroffPhiladelphia$33K
- Jose Pascual-LopezPhiladelphia$10K
- Murray CohenPhiladelphia$8K
- Alec BeekleyPhiladelphia$5K
- Benjamin BraslowPhiladelphia$4K
- Shariq RazaPhiladelphia$3K
- Jeremy CannonPhiladelphia$3K
- Alfred BoguckiPhiladelphia$1K
- Neeta ChaudharyPhiladelphia$763
- Mark SeamonPhiladelphia$299
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.